Jared Lund, MD
MOHS-Micrographic Surgery · Fresno, CANPI 1144424763
Payments from drug & device makers
Across 800 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Novartis$1K
- Johnson & Johnson$1K
- Incyte Corporation$939
- Sun Pharmaceutical Industries Inc.$743
- Regeneron Healthcare Solutions, Inc.$649
- plus $4K from 30 others
What the payments were for
- Food & beverage$14,13699%
- Education$1631%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 227 | $4,521 |
| Novartis | 75 | $1,498 |
| Johnson & Johnson | 111 | $1,474 |
| Incyte Corporation | 59 | $939 |
| Sun Pharmaceutical Industries Inc. | 37 | $743 |
| Regeneron Healthcare Solutions, Inc. | 26 | $649 |
| Lilly USA, LLC | 50 | $597 |
| Amgen | 27 | $535 |
| Galderma Laboratories, L.p. | 32 | $437 |
| LEO Pharma Inc. | 20 | $418 |
| Sanofi | 18 | $355 |
| UCB, Inc. | 21 | $355 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $228 |
| Pfizer | 11 | $209 |
| Surgenex LLC | 13 | $181 |
| E.r. Squibb & Sons, L.L.C. | 9 | $159 |
| VYNE Pharmaceuticals Inc. | 7 | $138 |
| Boehringer Ingelheim | 5 | $117 |
| Organogenesis Inc. | 3 | $99 |
| Arcutis Biotherapeutics, Inc. | 6 | $96 |
| Dermavant Sciences, Inc. | 4 | $92 |
| Botanix SB Inc | 3 | $58 |
| Almirall LLC | 3 | $55 |
| EPI Health, LLC | 3 | $55 |
| Verrica Pharmaceuticals Inc. | 2 | $44 |
| Polynovo North America LLC | 2 | $39 |
| Biofrontera Inc. | 2 | $33 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $16 |
| Prugen, Inc. Pharmaceuticals | 1 | $14 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$122
How this compares
$14,299 in reported general payments places this provider in the 85th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 96 | $6,591 |
| Cephalexin | 76 | $1,054 |
| Imiquimod | 23 | $640 |
| Doxycycline Hyclate | 19 | $172 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Fresno
- Leslie StoreyFresno$11K
- Michael MortazieOrange$1.2M
- Thuzar ShinSacramento$353K
- Sarah ArronBurlingame$223K
- Christopher Crosbyla Mesa$211K
- Abel TorresLoma Linda$136K
- Robert ScheinbergOceanside$129K
- Sherry RotundaOceanside$99K
- Sumaira AasiStanford$66K
- Daniel Zelacla Jolla$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.